An evening with Business Angels Switzerland

On Wednesday, November 18, Patrick Guye, Trilliome's co-founder and CEO, pitched Trilliome to Business Angels Switzerland at their 458th Dinner Meeting, at the Hôtel de la Paix in Lausanne. The questions after the pitch were sharp, and the conversations over coffee went further still.

Trilliome develops bioactives that act through the gut to support metabolic health and brain function as we age. Our first product ships in 2027.

Thank you to Ramon Zurbuchen and Verónica Espejo for a well-run evening, and to Paweł Krzysztofik for introducing Trilliome. It was a pleasure to pitch alongside Alsensia, Obios and Shape Biopharmaceuticals.

Were you in the room, or want to continue the conversation? Get in touch.